<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:con="http://www.w3.org/2000/10/swap/pim/contact#" xmlns:cinii="http://ci.nii.ac.jp/ns/1.0/">
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110002595777#article">
<foaf:isPrimaryTopicOf rdf:resource="http://ci.nii.ac.jp/naid/110002595777.rdf" />
<dc:title>EVALUATION OF INTRAVASCULAR HEMOLYSIS BY HAPTOGLOBIN ADMINISTRATION AFTER PROSTHETIC VALVE REPLACEMENT</dc:title>
<dc:creator>SHIOI KENSUKE</dc:creator>
<dc:creator>NAGATA YOSHIHISA</dc:creator>
<dc:creator>MASE TAKENORI</dc:creator>
<dc:creator>AOYAMA TAKAHIKO</dc:creator>
<dc:creator>KATOH SHINJI</dc:creator>
<dc:creator>TSUCHIOKA HIROMICHI</dc:creator>
<dc:publisher>社団法人日本循環器学会</dc:publisher>
<prism:publicationName>Japanese circulation journal</prism:publicationName>
<prism:issn>00471828</prism:issn>
<prism:volume>57</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>322</prism:startingPage>
<prism:endingPage>327</prism:endingPage>
<prism:publicationDate>1993-04-20</prism:publicationDate>
<dc:description>Although the measurement of serum haptoglobin (S-Hp) is of great use for evaluation of intravascular hemolysis, it is not applicable in patients with mechanical prosthetic valves because S-Hp is virtually absent. We administered haptoglobin preparation to 10 patients with Bjork-Shiley mitral prosthetic valves and 10 patients with the same aortic prosthetic valves. Serum haptoglobin levels were measured periodically afterwards. The maximum haptoglobin levels (Hp (max)), serum, haptoglobin reducing rate ((Hp-ΔHp)/ Δt) and expected haptoglobin disappering time (hours) were obtained from the subsequent samples. The screening studies which were performed at the same time were not predictors of difference in the 2 groups. On the other hand, serum haptoglobin reducing rate and expected haptoglobin disappearing time indicated that hemolysis is higher in patients with an aortic prosthetic valve than with a mitral prosthetic valve. This haptoglobin administration test seems to be useful for the comparative examination of the intravascular hemolysis caused by the difference in the position of the prosthetic valve.</dc:description>
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Haptoglobin_preparation" dc:title="Haptoglobin_preparation" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Intravascular_hemolysis" dc:title="Intravascular_hemolysis" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Bjork-Shiley_prosthetic_valve" dc:title="Bjork-Shiley_prosthetic_valve" />
<dc:date>1993-04-20</dc:date>
<cinii:naid>110002595777</cinii:naid>
<cinii:ncid>AA00690731</cinii:ncid>
<dc:language>ENG</dc:language>
<dc:source>NII-ELS</dc:source>
<cinii:fulltext>3</cinii:fulltext>
<dcterms:isPartOf rdf:resource="http://ci.nii.ac.jp/ncid/AA00690731" dc:title="Japanese circulation journal" />
<rdfs:seeAlso rdf:resource="http://search.jamas.or.jp/link/ui/1994070083" dc:title="医中誌 Web" />
</rdf:Description>
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110002595777#article" xml:lang="en">
<dc:title>EVALUATION OF INTRAVASCULAR HEMOLYSIS BY HAPTOGLOBIN ADMINISTRATION AFTER PROSTHETIC VALVE REPLACEMENT</dc:title>
<dc:creator>SHIOI KENSUKE</dc:creator>
<dc:creator>NAGATA YOSHIHISA</dc:creator>
<dc:creator>MASE TAKENORI</dc:creator>
<dc:creator>AOYAMA TAKAHIKO</dc:creator>
<dc:creator>KATOH SHINJI</dc:creator>
<dc:creator>TSUCHIOKA HIROMICHI</dc:creator>
<dc:publisher>Japanese Circulation Society</dc:publisher>
<prism:publicationName>Japanese circulation journal</prism:publicationName>
<dc:description>Although the measurement of serum haptoglobin (S-Hp) is of great use for evaluation of intravascular hemolysis, it is not applicable in patients with mechanical prosthetic valves because S-Hp is virtually absent. We administered haptoglobin preparation to 10 patients with Bjork-Shiley mitral prosthetic valves and 10 patients with the same aortic prosthetic valves. Serum haptoglobin levels were measured periodically afterwards. The maximum haptoglobin levels (Hp (max)), serum, haptoglobin reducing rate ((Hp-ΔHp)/ Δt) and expected haptoglobin disappering time (hours) were obtained from the subsequent samples. The screening studies which were performed at the same time were not predictors of difference in the 2 groups. On the other hand, serum haptoglobin reducing rate and expected haptoglobin disappearing time indicated that hemolysis is higher in patients with an aortic prosthetic valve than with a mitral prosthetic valve. This haptoglobin administration test seems to be useful for the comparative examination of the intravascular hemolysis caused by the difference in the position of the prosthetic valve.</dc:description>
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Haptoglobin_preparation" dc:title="Haptoglobin_preparation" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Intravascular_hemolysis" dc:title="Intravascular_hemolysis" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/Bjork-Shiley_prosthetic_valve" dc:title="Bjork-Shiley_prosthetic_valve" />
</rdf:Description>
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110002595777#article">
<foaf:depiction>
<foaf:Image rdf:about="http://ci.nii.ac.jp/pdfthumbnail/11/1100/110002/110002595777.jpg" />
</foaf:depiction>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003969019">
<foaf:name xml:lang="en">SHIOI KENSUKE</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003926579">
<foaf:name xml:lang="en">NAGATA YOSHIHISA</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003994668">
<foaf:name xml:lang="en">MASE TAKENORI</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003994669">
<foaf:name xml:lang="en">AOYAMA TAKAHIKO</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003994670">
<foaf:name xml:lang="en">KATOH SHINJI</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000003969022">
<foaf:name xml:lang="en">TSUCHIOKA HIROMICHI</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/The_Second_Department_of_Surgery%252C_Aichi_Medical_University">
<foaf:name xml:lang="en">The Second Department of Surgery, Aichi Medical University</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
</rdf:Description>
</rdf:RDF>

